Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 1997

View Archived Issues

Company Profile: NPS Pharmaceuticals

New antiinflammatory compounds disclosed by Glycomed

Boehringer Mannheim presents new calcium regulators

Merck & Co.'s newest D4 antagonists possess potent antipsychotic activity

New treatment approach for nasal congestion

Cephalon describes new indolocarbazoles for prostate disorders

New antipsychotics discovered at Duphar

Pfizer claims NOS inhibitors for CNS and inflammatory disorders

Merck continues to pursue peptidomimetic farnesyltransferase inhibitors

Proteus: six-month 1997 highlights

S-22068: effects on glucose tolerance and plasma insulin in mice

Lilly develops compounds for the common cold; selects development candidate

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

OGT-918 clinical development program begins

FDA approves Arthrotec, a new arthritis medication with NSAID efficacy and improved GI safety

Genetronics develops new transdermal delivery method suitable for large molecules and genes

FDA requests more information for RIGScan CR49 BLA

Scherer to develop Zydis ondansetron for Glaxo Wellcome

IBT-9302 inhibits multiple growth factor-induced SMC proliferation and migration

Salagen Tablets enters phase III development in Japan

Geron and Boehringer Mannheim will jointly develop telomerase-based assays